https://clinicaltrials.gov/ct2/show/NCT03307980?type=Intr&cond=hemophilia&lupd_s=04%2F10%2F2019&lupd_d=14
Condition : Hemophilia B
Intervention : Biological: SPK-9001
Sponsor : Pfizer
Recruiting
Long-term Safety and Efficacy Study of SPK-9001 in Individuals With Hemophilia B
NCT03307980
Thu, 12 Oct 2017 12:00:00 EDT
Last Update Posted: 04/24/19 07:45AM